Live Breaking News & Updates on டெரெக் வாலஸ்

Stay updated with breaking news from டெரெக் வாலஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dengue Vaccine Candidate Reinforced by Long-Term Safety


Takeda’s dengue vaccine candidate suggest that it could help with outbreak prevention
REPUBLIKA.CO.ID, JAKARTA Takeda Pharmaceutical Company Limited (Takeda) announced that its dengue vaccine candidate (TAK-003) demonstrated continued protection against dengue illness and hospitalization, regardless of an individual s previous dengue exposure, with no important safety risks identified through three years after vaccination in the ongoing pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial. TIDES enrolled more than 20.000 healthy children and adolescents ages four to 16 years in dengue-endemic countries in Latin America and Asia.
Dengue epidemics occur suddenly, and hospitals can become overwhelmed with severe disease cases and people seeking testing, said Managing Director Center for Clinical Management of Dengue and Dengue Haemorrhagic Fever, Negombo General Hospital, Sri Lanka and a primary investigator of the TIDES trial, LakKumar ....

Jakarta Raya , Sri Lanka , United States , Lakkumar Fernando , Derek Wallace , Berita Politik Perspektif Republika , European Union , Takeda Pharmaceutical Company Limited , Dengue Global Program Leader At Takeda , Pharmaceutical Company Limited , Dengue Efficacy Study , Latin America , Managing Director Center , Clinical Management , Dengue Haemorrhagic Fever , Negombo General Hospital , International Society , Travel Medicine , Vice President Dengue Global Program Leader , Update Berita Politik Perspektif Republika , ஜகார்த்தா ராய , ஸ்ரீ லங்கா , ஒன்றுபட்டது மாநிலங்களில் , டெரெக் வாலஸ் , ஐரோப்பிய தொழிற்சங்கம் , டாகேடா மருந்து நிறுவனம் வரையறுக்கப்பட்டவை ,